key: cord-0783135-2pq3uccl
authors: Indes, Jeffrey; Koleilat, Issam; Lipsitz, Evan
title: Reply
date: 2021-08-20
journal: J Vasc Surg
DOI: 10.1016/j.jvs.2021.05.009
sha: e21544851832cdee2bfaab5d03521d8ffe66e92b
doc_id: 783135
cord_uid: 2pq3uccl

nan

We would like to thank Roncati et al for their letter and comments related to our article. Approximately 1 year ago in the early stages of the coronavirus disease 2019 (COVID-19) pandemic, hospitals in New York City experienced some of the highest concentrations of cases in the United States. We cared for a great number of patients with arterial and/or venous thromboembolic complications related to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Among these were many patients with COVID-19 and acute arterial ischemia requiring emergent surgical treatment.

In addition to the greater mortality, we found these patients had a higher body mass index, higher average in-hospital D-dimer levels, and lower rates of antiplatelet usage. This constellation suggested that a generalized hyperinflammatory, hypercoagulable state, as nicely outlined in detail by Roncati et al in their letter to the editor, was primarily responsible. Finally, we found an unusual preponderance of large vessel thromboses, including those in the aortoiliac distribution. During the past year, the hypercoagulability seen in patients with COVID-19 has been increasingly elucidated and will continue to be further characterized. Although this has been an extremely difficult time for healthcare workers around the world, the opportunity for cross-specialty and global collaboration, as is illustrated by their letter to the editor and our article in the Journal, has been rewarding and hopefully will help expedite the characterization of these processes at a more detailed cellular and molecular level.

As we continue to treat patients with SARS-CoV-2 infection, we expect to encounter new and challenging obstacles such as the arterial and venous complications described. For example, we have seen in recent weeks the characterization of an even newer phenomenon, a condition known as SARS-CoV-2 vaccineeinduced immune thrombotic thrombocytopenia. As was recently demonstrated in a New England Journal article, the mechanism of this hypercoagulable disorder related to COVID-19 vaccination is closely related to that which leads to heparin-induced thrombocytopenia. 1 This requires treatment with noneheparin anticoagulant agents. It is important to differentiate hypercoagulable complications such as these in patients with SAR-CoV-2 infection because the treatment implications could differ. As vascular disease experts, it is inherent for us to understand the mechanisms underlying these complications whether or not they require surgical intervention. 

We read "Popliteal Scoring Assessment for Vascular Extremity Injuries in Trauma (POPSAVEIT) Study," which communicated the results of a multicenter retrospective analysis of 355 patients with popliteal vascular injury from 2007 to 2018. 1 On multivariate regression the significant preoperative risk factors independently associated with amputation in the final model included a systolic blood pressure of <90 mm Hg (odds ratio [OR], 3.2; P ¼ .027), associated orthopedic injury (OR, 4.9; P ¼ .014), and lack of preoperative pedal Doppler signals (OR, 5.5; P ¼ .002). The receiver operating characteristic curve for the score generation training group had an area under the curve of 0.704 (standard error; 0.039, 95% confidence interval, 0.628-0.779) and a score was found to maximize sensitivity (85%) and specificity (49%) for high-risk of amputation. 1 From this, the team endeavored to formulate a simple tool.

Distal ischemia is one of the key variables that need to be considered in amputation salvageddecisions and we applaud authors for their attempt to rectify ambiguity persisted in grading ischemia in prior scoring tools. we too, endeavored to correct the mentioned short fall by creating the Modified Kornilov Extremity Ischemia Index to rapidly identify distal perfusion status 2 (Table) . We fear that POPSAVEIT will join an array of prior tools that fail to reach the needed accuracy to support complex decision-making in lower extremity vascular trauma. In our experience from the Sri Lankan Civil War, this ambiguity arises from gaps in knowledge of complex interrelations of variables pertinent to the limb salvage. This factor is amplified by an array of research communications based on data registries that lack the granularity that is necessary to understand these complexities. Finally, there is a diverse spectrum of military to civilian context in which these are going to be applied. 3, 4 Simplified tools that are created to enhanced clinical usefulness do not reach accuracy in real-world clinical situations with complex interactions between multiple competing variables. This dilemma was recently addressed by Perkins et al by creating Bayesian Network model through a supervised machine learning approach. 5, 6 In the current context, this important, complex, but uncommon problem in salvage decision-making in mangled extremity remains, at best, ambiguous.

Early experience with arterial thromboembolic complications in patients with COVID-19

Renin-angiotensin system: the unexpected flaw inside the human immune system revealed by SARS-CoV-2

Endothelial cell infection and endotheliitis in COVID-19

Type 3 hypersensitivity in COVID-19 vasculitis

Circulating endothelial cells as a marker of endothelial injury in severe COVID-19

A proof of evidence supporting abnormal immunothrombosis in severe COVID-19: naked megakaryocyte nuclei increase in the bone marrow and lungs of critically ill patients

The COVID-19 arterial thromboembolic complications: from inflammation to immunothrombosis through antiphospholipid autoantibodies

Popliteal scoring assessment for vascular extremity injuries in trauma study

A new ischemic grading system to aid combat extremity vascular injury decision making

Rich's vascular trauma

Outcomes of popliteal vascular injuries at Sri Lankan war-front military hospital: case series of 44 cases